Home

Thyrocare Technologies Ltd PE Ratio

Image

Thyrocare Technologies Ltd

NSE: THYROCARE

PE

52.1

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Thyrocare Technologies Ltd is 52.1 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Thyrocare Technologies Ltd changed from 29.6 on March 2020 to 44.3 on March 2024 . This represents a CAGR of 8.40% over 5 years.
  • The Latest Trading Price of Thyrocare Technologies Ltd is ₹ 824.7 as of 15 Jan 15:24 .
  • The PE Ratio of Healthcare Industry has changed from 34.6 to 62.9 in 5 years. This represents a CAGR of 12.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.9. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Thyrocare Technologies Ltd

No data available

Company Fundamentals for Thyrocare Technologies Ltd

Image

Thyrocare Technologies Ltd

NSE: THYROCARE

Share Price

₹ 824.7

-0.60 (-0.07%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Thyrocare Technologies Ltd

1M

1Y

3Y

5Y

Monitoring Thyrocare Technologies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025825.3
13 Jan 2025823.45
10 Jan 2025861.75
09 Jan 2025915.85
08 Jan 2025935
07 Jan 2025950.05
06 Jan 20251017.9
03 Jan 2025913.3
02 Jan 2025907.65
01 Jan 2025922.1

SWOT Analysis Of Thyrocare Technologies Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Thyrocare Technologies Ltd

Asset Value vs Market Value of Thyrocare Technologies Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Thyrocare Technologies Ltd4373
Max Healthcare Institute Ltd105656
Apollo Hospitals Enterprise Ltd96403
Fortis Healthcare Ltd50103
Syngene International Ltd33340

PE Ratio of Thyrocare Technologies Ltd Explained

``

4373

Market cap

83

Earnings

52.1X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Thyrocare Technologies Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Thyrocare Technologies Ltd

No data available

* All values are in %

About Thyrocare Technologies Ltd

  • Thyrocare Technologies Limited was incorporated in January, 2000.
  • The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
  • Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
  • The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).

Thyrocare Technologies Ltd News Hub

Thyrocare Technologies AGM scheduled

Thyrocare Technologies announced that the Annual General Meeting (AGM) of the company will be held o

Read more

2024-08-06 00:00:00

Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab

Thyrocare Technologies said that it shall have access to 11 centres of Vimta Labs at the locations s

Read more

2024-08-30 00:00:00

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and p

Read more

2024-08-30 00:00:00

Thyrocare Technologies announces cessation of director

Thyrocare Technologies announced the cessation of Neetin Shivajirao Desai (DIN No: 02622364) as Inde

Read more

2024-09-19 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Thyrocare Technologies Ltd

What is the current PE Ratio of Thyrocare Technologies Ltd?

The Current PE Ratio of Thyrocare Technologies Ltd is 52.07 as on 15 Jan 2025.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 62.9 as on 15 Jan 2025.

What was the PE Ratio of Thyrocare Technologies Ltd last year?

The PE Ratio of Thyrocare Technologies Ltd was 35.28 last year, now the PE ratio is 52.07, showing a year-on-year growth of 47.6%.

What does the PE Ratio of Thyrocare Technologies Ltd indicate about its stock?

The PE Ratio of Thyrocare Technologies Ltd is 52.07. This ratio indicates that investors are willing to pay 52.07 times the earnings per share for each share of Thyrocare Technologies Ltd.

What is the PE Ratio Growth of Thyrocare Technologies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Thyrocare Technologies Ltd grew by 47.6% whereas, the EPS ratio grew by 10.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions